Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MediWound (MDWD) Equity Average (2016 - 2025)

Historic Equity Average for MediWound (MDWD) over the last 12 years, with Q1 2025 value amounting to $31.2 million.

  • MediWound's Equity Average rose 1392.67% to $31.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $31.2 million, marking a year-over-year increase of 1392.67%. This contributed to the annual value of $31.4 million for FY2024, which is 4761.11% up from last year.
  • As of Q1 2025, MediWound's Equity Average stood at $31.2 million, which was up 1392.67% from $32.7 million recorded in Q4 2024.
  • MediWound's Equity Average's 5-year high stood at $34.1 million during Q2 2023, with a 5-year trough of -$2.7 million in Q4 2021.
  • Its 5-year average for Equity Average is $15.1 million, with a median of $6.3 million in 2022.
  • As far as peak fluctuations go, MediWound's Equity Average plummeted by 14464.15% in 2022, and later skyrocketed by 2362724.14% in 2023.
  • Over the past 5 years, MediWound's Equity Average (Quarter) stood at -$2.7 million in 2021, then surged by 332.65% to $6.3 million in 2022, then skyrocketed by 414.28% to $32.3 million in 2023, then rose by 1.15% to $32.7 million in 2024, then fell by 4.53% to $31.2 million in 2025.
  • Its last three reported values are $31.2 million in Q1 2025, $32.7 million for Q4 2024, and $27.4 million during Q1 2024.